LNSR
LENSAR Emerges Stronger, Focused on Growth After FTC-Driven Acquisition Halt
The Q4 2025 financial results conference call for LENSAR, a leading eye care company, revealed a resilient and growth-oriented strategy despite the termination of a joint acquisition with Alcon in March 2025. The decision was driven by the Federal Trade Commission's (FTC) intention to enjoin the merger. During